COVID-19 experimental drug
The Latest
-
Moderna, Catalent To Make 100 Million Doses Of COVID-19 Vaccines For US
Shares of Moderna have more than tripled this year, as investors rush to the stock for its promising results. 
Shares of Moderna have more than tripled this year, as investors rush to the stock for its promising results.
